MedPage Today September 28, 2024
Joyce Frieden

— “People will continue to have ample, affordable choices”

Average premiums and benefits for Medicare Advantage (MA) and Medicare Part D drug plans will remain stable in 2025, CMS officials said Friday.

“Bottom line: average premiums, benefits and plan choices for Medicare Advantage and the Medicare Part D prescription drug program will remain stable in 2025 just as they were in 2024,” Meena Seshamani, MD, PhD, director of the CMS Center for Medicare, said on a call with reporters. “Average premiums are projected to decline in both the Medicare Advantage and Part D program from 2024 to 2025.”

“CMS has taken significant steps over the last few years — improved payment accuracy and improved protection for people with Medicare —...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Medicare Advantage, Patient / Consumer
CMS Launches New Program for Mental Health, OUD Treatment
How Medicare Negotiated Drug Prices Compare to Other Countries
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Innovating Without Compromising Integration: Considerations For Medicare
How the Federal Government Could Push People Toward Medicare Advantage – And Replace Traditional Medicare

Share This Article